Technology News and Research

RSS

Bruker announces NIST order for AVANCE III 900 NMR spectrometer

Bruker Corporation, the leader in analytical magnetic resonance instrumentation, today announces a major order from the National Institute of Standards and Technology (NIST) for its ultra-high field AVANCE™ III 900 US2 NMR spectrometer.

7 Sep 2010

RevMed secures contract with Medical Investment to produce fixed needle safety syringe

RevMed has secured a binding 5 Year contract to produce 5M syringes/month of its 3mL fixed needle safety syringe with Medical Investment Group, LLC (MIG). MIG, a Massachusetts Limited Liability Company, will fulfill this obligation through its relationship with an internationally certified global medical device manufacturer.

7 Sep 2010

FDA grants IRIS clearance for analysis of synovial fluid with iQ200, iRICELL automated microscopy analyzers

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.

7 Sep 2010

NextGen executes agreement with MKMG to deploy EHR solution

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Mount Kisco Medical Group, PC (MKMG) to deploy NextGen Ambulatory EHR (Electronic Health Record), NextGen Practice Management, and the NextGen Patient portal.

7 Sep 2010

Medtronic announces international launch of Resolute Integrity Stent System

Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the treatment of coronary artery disease, a leading cause of death and poor quality of life.

7 Sep 2010

DSM, PolyTherics enter agreement for HiPEG IFN alpha-2a product development

DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.

7 Sep 2010

International Iberian Nanotechnology Laboratory orders for Vistec's EBPG5200 electron-beam lithography system

Vistec Lithography, a leading supplier of advanced electron-beam lithography systems has announced today that the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal has placed an order for Vistec's electron-beam lithography system EBPG5200. The Portuguese Laboratory is the first fully international research organization in Europe in the field of nanoscience and nanotechnology.

7 Sep 2010

DSM Pharma launches InnoSyn route scouting services for pharmaceutical customers

DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSyn™ route scouting services. In response to the increasing interest of pharmaceutical customers to outsource the development of robust low-cost manufacturing routes, DSM is offering focused and flexible stand alone route scouting services.

7 Sep 2010

Protagen AG announces € 10.0 Million for second round of finance totaling

Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis announced today a second round of finance totalling a volume of € 10.0 Million.

7 Sep 2010

Precision receives stay for patent infringement litigation by Cellectis

Precision BioSciences, Inc., today announced that the United States District Court for the Eastern District of North Carolina has granted Precision's request to stay patent infringement litigation brought against Precision by Cellectis, SA.

7 Sep 2010

Researchers to develop new treatment strategy for cancer

Cancer is a difficult disease to treat because it's a personal disease. Each case is unique and based on a combination of environmental and genetic factors. Conventional chemotherapy employs treatment with one or more drugs, assuming that these medicines are able to both "diagnose" and "treat" the affected cells. Many of the side effects experienced by chemotherapy patients are due to the fact that the drugs they are taking aren't selective enough.

7 Sep 2010

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

Only one in ten people know that radiotherapy helps cure forty per cent of cancer patients according to new figures published by Cancer Research UK today.

7 Sep 2010

TimeTemp's shelf-life indicator for food will help Norwegian retailers reduce waste

Norwegian food retailers discard over 50,000 tonnes of food annually - much of it of perfectly good quality. New technology from Norway could substantially reduce this wastefulness.

4 Sep 2010

Kavli Day 2010 at Norwegian University of Science and Technology

In celebration of Kavli Prize Week, the Norwegian University of Science and Technology (NTNU), the Norwegian Academy of Science and Letters, and the Kavli Foundation will hold a series of lectures and events on 9 September 2010 in Trondheim, Norway at the NTNU campus. The event features a number of 2010 Kavli Prize Laureates. The festivities continue after the official celebration, with two symposia sponsored by NTNU, one in neuroscience and one in nanoscience.

4 Sep 2010

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

A study comparing a University of Pennsylvania method for evaluating a dog's susceptibility to hip dysplasia to the traditional American method has shown that 80 percent of dogs judged to be normal by the traditional method are actually at risk for developing osteoarthritis and hip dysplasia, according to the Penn method.

4 Sep 2010

Maryland Stem Cell Research Commission partners with NIH, NIST to host symposium on stem cell research

The Maryland Stem Cell Research Commission will host the Third Annual Maryland Stem Cell Research Symposium in partnership with the National Institutes of Health and the National Institute of Standards and Technology on Wednesday, Sept. 22, 2010.

4 Sep 2010

CyberKnife radiosurgery treatment effective for prostate cancer without side effects

CyberKnife radiosurgery treatment for prostate cancer is rapid, effective and has no side effects, with the added benefit of being non-invasive.

3 Sep 2010

Researchers develop gLQ Model to determine optimal dose level, treatment schedules for high-dose radiation therapies

There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers.Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute may have solved the problem by developing a new mathematical model that encompasses all dose levels.

3 Sep 2010

ImmunoCellular Therapeutics updates accomplishments in Letter to Shareholders

As the summer comes to a close, I wanted to update you on the Company's accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges for many small biotechnology companies. Today, IMUC is in its best financial position ever and well positioned to validate the success it achieved in a Phase I trial for ICT-107, its dendritic cell-based cancer vaccine product candidate.

3 Sep 2010

24 Hour Fitness partners with Safran Group to offer cardless check-in for members

24 Hour Fitness, the largest U.S. fitness chain and a leading health club industry pioneer, is pleased to announce a new convenient, secure and environmentally friendly cardless check-in option for members. 24 Hour Fitness has partnered with MorphoTrak (Safran Group), part of the world's largest, most trusted provider of biometric technology, to offer cardless check-in for its members at all 420 clubs by the end of 2010.

3 Sep 2010

Technology News and Research

Bruker announces NIST order for AVANCE III 900 NMR spectrometer

RevMed secures contract with Medical Investment to produce fixed needle safety syringe

FDA grants IRIS clearance for analysis of synovial fluid with iQ200, iRICELL automated microscopy analyzers

NextGen executes agreement with MKMG to deploy EHR solution

Medtronic announces international launch of Resolute Integrity Stent System

DSM, PolyTherics enter agreement for HiPEG IFN alpha-2a product development

International Iberian Nanotechnology Laboratory orders for Vistec's EBPG5200 electron-beam lithography system

DSM Pharma launches InnoSyn route scouting services for pharmaceutical customers

Protagen AG announces € 10.0 Million for second round of finance totaling

Precision receives stay for patent infringement litigation by Cellectis

Researchers to develop new treatment strategy for cancer

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

TimeTemp's shelf-life indicator for food will help Norwegian retailers reduce waste

Kavli Day 2010 at Norwegian University of Science and Technology

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

Maryland Stem Cell Research Commission partners with NIH, NIST to host symposium on stem cell research

CyberKnife radiosurgery treatment effective for prostate cancer without side effects

Researchers develop gLQ Model to determine optimal dose level, treatment schedules for high-dose radiation therapies

ImmunoCellular Therapeutics updates accomplishments in Letter to Shareholders

24 Hour Fitness partners with Safran Group to offer cardless check-in for members

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News